Cibus Inc
CBUS
Company Profile
Business description
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Contact
6455 Nancy Ridge Drive
San DiegoCA92121
USAT: +1 858 450-0008
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
118
Stocks News & Analysis
stocks
SpaceX: What investors need to know about its enormous upcoming IPO
Morningstar launches research coverage of SpaceX.
stocks
Fair value lifts for toll road operator as Aussie fuel supply steadies
An Australian fuel shortage is becoming increasingly unlikely, a relief for ASX toll road operator.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,966.00 | 17.10 | 0.19% |
| CAC 40 | 8,230.22 | 83.63 | 1.03% |
| DAX 40 | 25,266.55 | 263.51 | 1.05% |
| Dow JONES (US) | 51,078.88 | 46.42 | 0.09% |
| FTSE 100 | 10,382.46 | 43.51 | 0.42% |
| HKSE | 26,029.84 | 631.66 | 2.49% |
| NASDAQ | 27,086.81 | 114.19 | 0.42% |
| Nikkei 225 | 66,734.24 | 200.09 | -0.30% |
| NZX 50 Index | 13,170.71 | 73.84 | -0.56% |
| S&P 500 | 7,599.96 | 19.90 | 0.26% |
| S&P/ASX 200 | 8,724.40 | 17.70 | 0.20% |
| SSE Composite Index | 4,075.10 | 17.36 | 0.43% |